BRIEF published on 06/27/2024 at 18:20, 1 year 5 months ago Dermapharm Holding SE : l'Assemblée générale annuelle décide de distribuer un dividende de 0,88 EUR par action Dividende Assemblée Générale Annuelle Perspectives Financières Dermapharm
BRIEF published on 06/27/2024 at 18:20, 1 year 5 months ago Dermapharm Holding SE: Annual General Meeting Resolves Dividend Distribution of EUR 0.88 Per Share Annual General Meeting Dividend Financial Outlook Dermapharm
PRESS RELEASE published on 06/27/2024 at 18:15, 1 year 5 months ago Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.88 per share Dermapharm Holding SE's Annual General Meeting approves EUR 0.88 per share dividend distribution for 2024. Board actions confirmed. Outlook and acquisitions strategies highlighted Annual General Meeting Acquisitions Outlook Dividend Distribution Dermapharm Holding SE
BRIEF published on 05/15/2024 at 07:35, 1 year 6 months ago Dermapharm Holding SE annonce une baisse de son chiffre d'affaires au premier trimestre 2024 dans un contexte de forte croissance des produits pharmaceutiques de marque Résultats Financiers Croissance Organique Résilience Du Marché Produits De Santé Produits Pharmaceutiques De Marque
BRIEF published on 05/15/2024 at 07:35, 1 year 6 months ago Dermapharm Holding SE Reports Decline in Q1 2024 Revenue Amidst Strong Branded Pharmaceuticals Growth Financial Results Organic Growth Market Resilience Healthcare Products Branded Pharmaceuticals
PRESS RELEASE published on 05/15/2024 at 07:30, 1 year 6 months ago Strong organic growth in core markets underscores resilience of Dermapharm Holding SE's corporate strategy Dermapharm Holding SE reports strong organic growth in core markets with resilient corporate strategy in Q1 2024 Organic Growth Q1 2024 Core Markets Dermapharm Holding SE Resilient Strategy
BRIEF published on 03/28/2024 at 07:35, 1 year 8 months ago Dermapharm Holding SE répond à toutes les attentes dans un contexte économique difficile Rapport Annuel 2023 Défis Économiques Dermapharm Holding SE Industrie Pharmaceutique Attentes De Croissance
BRIEF published on 03/28/2024 at 07:35, 1 year 8 months ago Dermapharm Holding SE Meets All Expectations in Challenging Economic Climate Pharmaceutical Industry Annual Report 2023 Economic Challenges Dermapharm Holding SE Growth Expectations
PRESS RELEASE published on 03/28/2024 at 07:30, 1 year 8 months ago Dermapharm Holding SE fulfils all expectations despite multiple macroeconomic challenges Dermapharm Holding SE fulfils all expectations in 2023 despite macroeconomic challenges, with revenue up by 10.8% to EUR 1,135.4 million and adjusted EBITDA margin at 27.3% Pharmaceutical Industry Revenue Growth EBITDA Margin Annual Report Dermapharm Holding SE
BRIEF published on 03/14/2024 at 07:35, 1 year 8 months ago Dermapharm Holding SE atteint l'extrémité supérieure de sa fourchette d'orientation malgré les défis Résultats Financiers Hausse Des Revenus Médicaments Dermapharm Holding SE Produits De Santé
Published on 12/05/2025 at 17:15, 51 minutes ago TRX GOLD Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 17:00, 1 hour 6 minutes ago Three Trillion-Dollar Frontiers, One Technology: How SMX Is Everywhere at Once
Published on 12/05/2025 at 16:00, 2 hours 6 minutes ago SMX Didn't Change Its Story; The World Finally Connected the Dots
Published on 12/05/2025 at 15:45, 2 hours 21 minutes ago Critical Elements announce la clôture d'un placement privé de 7,0 $ million ca par voie de prise ferme
Published on 12/05/2025 at 15:45, 2 hours 21 minutes ago Critical Elements Announces Closing of C$7.0 Million Bought Deal Life Private Placement
Published on 12/05/2025 at 17:46, 20 minutes ago Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds
Published on 12/05/2025 at 17:00, 1 hour 6 minutes ago EQS-Adhoc: The NAGA Group AG adjusts guidance for financial year 2025 following continued low volatility and weaker year-end performance
Published on 12/05/2025 at 16:25, 1 hour 41 minutes ago 4YFN26 Awards: Meet the Top 20 startups building the future
Published on 12/05/2025 at 16:10, 1 hour 56 minutes ago Reorganization of the Eckert & Ziegler Executive Board
Published on 12/05/2025 at 17:18, 48 minutes ago La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 48 minutes ago The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 2 hours 55 minutes ago Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 2 hours 55 minutes ago Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 4 hours 8 minutes ago RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
